View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
President
CISIDAT Consorcio de Investigación en VIHISIDA y Tuberculosis A.C.
Infectious Diseases Consultant
Cuernavaca, Mexico
Associate Researcher
CISIDAT
Cuernavaca, Mexico
Chief, Infectious Diseases Department
Infection Prevention and Control
Red Carmen
Mexico City, Mexico
This program has been made available online.
Expert summaries of AASLD, EASL, and APASL guidance on monitoring and treating chronic hepatitis B and delta viral infections, from Clinical Care Options (CCO)
Maria Buti, MD
Paul Y. Kwo, MD
Grace LH Wong, MD
Released: December 1, 2022
Prof George Lau: proactive monitoring and treatment are necessary for all patients with CHB, regardless of age, from Clinical Care Options (CCO)
George Lau, MBBS (HKU), MD (HKU), FRCP (Edin, Lond), FAASLD (USA)
Released: December 1, 2022
Expert summaries of AASLD, EASL, APASL guidance on monitoring and treating chronic hepatitis B and delta infections, with Maria Buti, Paul Kwo, Grace Wong
Maria Buti, MD
Paul Y. Kwo, MD
Grace LH Wong, MD
Released: December 1, 2022
Clinical Care Options (CCO) expert analysis of new data from IDWeek and HIV Glasgow 2022, provided by expert HIV faculty
Chloe Orkin, MBChB, FRCP, MD
Babafemi Taiwo, MBBS
Released: November 30, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
